National Research Corporation (NRC)
USD 17.18
(-2.83%)
USD 17.18
(-2.83%)
| Year | Total Assets | Total Assets Growth |
|---|---|---|
| 2023 | 122.43 Million USD | -6.15% |
| 2022 | 130.46 Million USD | -17.19% |
| 2021 | 157.54 Million USD | 18.08% |
| 2020 | 133.42 Million USD | 20.54% |
| 2019 | 110.68 Million USD | 2.79% |
| 2018 | 107.68 Million USD | -15.42% |
| 2017 | 127.31 Million USD | 5.55% |
| 2016 | 120.62 Million USD | -6.56% |
| 2015 | 129.09 Million USD | -0.32% |
| 2014 | 129.51 Million USD | 16.68% |
| 2013 | 110.99 Million USD | 10.94% |
| 2012 | 100.04 Million USD | -0.63% |
| 2011 | 100.67 Million USD | 5.29% |
| 2010 | 95.61 Million USD | 31.89% |
| 2009 | 72.49 Million USD | 2.62% |
| 2008 | 70.64 Million USD | 14.19% |
| 2007 | 61.86 Million USD | 0.55% |
| 2006 | 61.53 Million USD | 37.73% |
| 2005 | 44.67 Million USD | -6.84% |
| 2004 | 47.95 Million USD | 4.99% |
| 2003 | 45.67 Million USD | 17.62% |
| 2002 | 38.83 Million USD | 14.98% |
| 2001 | 33.77 Million USD | 6.75% |
| 2000 | 31.63 Million USD | 7.98% |
| 1999 | 29.3 Million USD | 11.41% |
| 1998 | 26.3 Million USD | 16.37% |
| 1997 | 22.6 Million USD | 264.52% |
| 1996 | 6.2 Million USD | 24.1% |
| 1995 | 4.99 Million USD | 41.17% |
| 1994 | 3.53 Million USD | 158.7% |
| 1993 | 1.36 Million USD | 0.0% |
| Year | Total Assets | Total Assets Growth |
|---|---|---|
| 2024 Q1 | 120.91 Million USD | -1.25% |
| 2024 Q2 | 119.09 Million USD | -1.5% |
| 2024 Q3 | 131.79 Million USD | 10.66% |
| 2023 Q4 | 122.43 Million USD | 1.92% |
| 2023 FY | 122.43 Million USD | -6.15% |
| 2023 Q3 | 120.13 Million USD | -10.1% |
| 2023 Q2 | 133.62 Million USD | -0.51% |
| 2023 Q1 | 134.3 Million USD | 2.95% |
| 2022 Q1 | 153.15 Million USD | -2.78% |
| 2022 Q2 | 136.23 Million USD | -11.05% |
| 2022 Q3 | 134.98 Million USD | -0.92% |
| 2022 Q4 | 130.46 Million USD | -3.35% |
| 2022 FY | 130.46 Million USD | -17.19% |
| 2021 Q4 | 157.54 Million USD | 0.87% |
| 2021 Q1 | 146.87 Million USD | 10.08% |
| 2021 Q2 | 151.84 Million USD | 3.38% |
| 2021 FY | 157.54 Million USD | 18.08% |
| 2021 Q3 | 156.18 Million USD | 2.86% |
| 2020 Q1 | 115.85 Million USD | 4.67% |
| 2020 Q2 | 116.78 Million USD | 0.8% |
| 2020 Q3 | 127.24 Million USD | 8.96% |
| 2020 Q4 | 133.42 Million USD | 4.85% |
| 2020 FY | 133.42 Million USD | 20.54% |
| 2019 Q4 | 110.68 Million USD | 2.82% |
| 2019 Q3 | 107.64 Million USD | 3.24% |
| 2019 Q2 | 104.27 Million USD | -0.28% |
| 2019 Q1 | 104.57 Million USD | -2.89% |
| 2019 FY | 110.68 Million USD | 2.79% |
| 2018 Q3 | 108.71 Million USD | 5.67% |
| 2018 Q4 | 107.68 Million USD | -0.95% |
| 2018 Q2 | 102.88 Million USD | -21.45% |
| 2018 Q1 | 130.97 Million USD | 2.87% |
| 2018 FY | 107.68 Million USD | -15.42% |
| 2017 Q4 | 127.31 Million USD | -1.11% |
| 2017 FY | 127.31 Million USD | 5.55% |
| 2017 Q1 | 126.05 Million USD | 4.51% |
| 2017 Q2 | 124.57 Million USD | -1.18% |
| 2017 Q3 | 128.74 Million USD | 3.34% |
| 2016 FY | 120.62 Million USD | -6.56% |
| 2016 Q1 | 118.37 Million USD | -8.31% |
| 2016 Q2 | 116.49 Million USD | -1.58% |
| 2016 Q3 | 119.3 Million USD | 2.41% |
| 2016 Q4 | 120.62 Million USD | 1.11% |
| 2015 FY | 129.09 Million USD | -0.32% |
| 2015 Q2 | 131.04 Million USD | 2.02% |
| 2015 Q4 | 129.09 Million USD | -0.29% |
| 2015 Q3 | 129.47 Million USD | -1.2% |
| 2015 Q1 | 128.45 Million USD | -0.82% |
| 2014 Q4 | 129.51 Million USD | 1.93% |
| 2014 Q2 | 121.86 Million USD | 4.81% |
| 2014 Q1 | 116.27 Million USD | 4.76% |
| 2014 FY | 129.51 Million USD | 16.68% |
| 2014 Q3 | 127.06 Million USD | 4.26% |
| 2013 Q2 | 104.89 Million USD | 1.35% |
| 2013 Q4 | 110.99 Million USD | 0.98% |
| 2013 Q1 | 103.5 Million USD | 3.45% |
| 2013 FY | 110.99 Million USD | 10.94% |
| 2013 Q3 | 109.91 Million USD | 4.78% |
| 2012 Q3 | 109.42 Million USD | 3.63% |
| 2012 Q2 | 105.59 Million USD | 2.14% |
| 2012 Q1 | 103.37 Million USD | 2.68% |
| 2012 Q4 | 100.04 Million USD | -8.57% |
| 2012 FY | 100.04 Million USD | -0.63% |
| 2011 Q4 | 100.67 Million USD | -0.27% |
| 2011 Q2 | 100.29 Million USD | 2.34% |
| 2011 Q1 | 98 Million USD | 2.33% |
| 2011 FY | 100.67 Million USD | 5.29% |
| 2011 Q3 | 100.95 Million USD | 0.65% |
| 2010 Q1 | 77.38 Million USD | 6.74% |
| 2010 FY | 95.61 Million USD | 31.89% |
| 2010 Q3 | 93.4 Million USD | 18.49% |
| 2010 Q4 | 95.77 Million USD | 2.54% |
| 2010 Q2 | 78.82 Million USD | 1.86% |
| 2009 Q1 | 73.33 Million USD | 1.65% |
| 2009 Q2 | 72.26 Million USD | -1.46% |
| 2009 Q3 | 74.4 Million USD | 2.96% |
| 2009 Q4 | 72.49 Million USD | -2.56% |
| 2009 FY | 72.49 Million USD | 2.62% |
| 2008 Q4 | 72.14 Million USD | 18.73% |
| 2008 Q3 | 60.76 Million USD | -0.66% |
| 2008 Q2 | 61.16 Million USD | -1.65% |
| 2008 Q1 | 62.19 Million USD | 0.53% |
| 2008 FY | 70.64 Million USD | 14.19% |
| 2007 FY | 61.86 Million USD | 0.55% |
| 2007 Q1 | 62.52 Million USD | 1.61% |
| 2007 Q2 | 63.29 Million USD | 1.23% |
| 2007 Q3 | 64.04 Million USD | 1.18% |
| 2007 Q4 | 61.86 Million USD | -3.39% |
| 2006 Q4 | 61.53 Million USD | 2.1% |
| 2006 FY | 61.53 Million USD | 37.73% |
| 2006 Q1 | 44.22 Million USD | -1.01% |
| 2006 Q3 | 60.26 Million USD | -2.4% |
| 2006 Q2 | 61.74 Million USD | 39.63% |
| 2005 Q4 | 44.67 Million USD | -9.24% |
| 2005 Q2 | 48.36 Million USD | -0.7% |
| 2005 Q1 | 48.7 Million USD | 1.57% |
| 2005 FY | 44.67 Million USD | -6.84% |
| 2005 Q3 | 49.22 Million USD | 1.78% |
| 2004 FY | 47.95 Million USD | 4.99% |
| 2004 Q4 | 47.95 Million USD | 3.73% |
| 2004 Q3 | 46.22 Million USD | -0.79% |
| 2004 Q2 | 46.59 Million USD | 0.72% |
| 2004 Q1 | 46.26 Million USD | 1.29% |
| 2003 Q1 | 41.84 Million USD | 7.77% |
| 2003 Q2 | 43.15 Million USD | 3.13% |
| 2003 Q3 | 43.37 Million USD | 0.5% |
| 2003 Q4 | 45.67 Million USD | 5.3% |
| 2003 FY | 45.67 Million USD | 17.62% |
| 2002 Q2 | 35.91 Million USD | 5.11% |
| 2002 Q3 | 37.26 Million USD | 3.76% |
| 2002 FY | 38.83 Million USD | 14.98% |
| 2002 Q4 | 38.83 Million USD | 4.22% |
| 2002 Q1 | 34.16 Million USD | 1.16% |
| 2001 Q2 | 33.08 Million USD | 3.74% |
| 2001 Q4 | 33.77 Million USD | 1.73% |
| 2001 Q3 | 33.19 Million USD | 0.33% |
| 2001 Q1 | 31.89 Million USD | 0.82% |
| 2001 FY | 33.77 Million USD | 6.75% |
| 2000 FY | 31.63 Million USD | 7.98% |
| 2000 Q1 | 30.52 Million USD | 4.19% |
| 2000 Q3 | 32.32 Million USD | 0.99% |
| 2000 Q4 | 31.63 Million USD | -2.12% |
| 2000 Q2 | 32 Million USD | 4.84% |
| 1999 Q1 | 25.9 Million USD | -1.52% |
| 1999 FY | 29.3 Million USD | 11.41% |
| 1999 Q2 | 25.3 Million USD | -2.32% |
| 1999 Q4 | 29.3 Million USD | 7.72% |
| 1999 Q3 | 27.2 Million USD | 7.51% |
| 1998 Q2 | 25.4 Million USD | 9.96% |
| 1998 FY | 26.3 Million USD | 16.37% |
| 1998 Q1 | 23.1 Million USD | 2.21% |
| 1998 Q4 | 26.3 Million USD | 8.68% |
| 1998 Q3 | 24.2 Million USD | -4.72% |
| 1997 FY | 22.6 Million USD | 264.52% |
| 1997 Q4 | 22.6 Million USD | 0.0% |
| 1996 FY | 6.2 Million USD | 24.1% |
| 1995 FY | 4.99 Million USD | 41.17% |
| 1994 FY | 3.53 Million USD | 158.7% |
| 1993 FY | 1.36 Million USD | 0.0% |
| Name | Total Assets | Total Assets Difference |
|---|---|---|
| Inovalon Holdings, Inc. | 1.97 Billion USD | 93.789% |
| GE HealthCare Technologies Inc. | 32.45 Billion USD | 99.623% |
| Sharecare, Inc. | 613.63 Million USD | 80.047% |
| Progyny, Inc. | 756.62 Million USD | 83.818% |
| Aclarion, Inc. | 2.45 Million USD | -4877.571% |
| CareMax, Inc. | 623.3 Million USD | 80.357% |
| Simulations Plus, Inc. | 196.63 Million USD | 37.735% |
| CareCloud, Inc. | 79.51 Million USD | -53.982% |
| Forian Inc. | 59.37 Million USD | -106.206% |
| Bullfrog AI Holdings, Inc. Warrants | 2.77 Million USD | -4309.624% |
| Bullfrog AI Holdings, Inc. Common Stock | 2.77 Million USD | -4309.624% |
| Minerva Surgical, Inc. | 68.9 Million USD | -77.702% |
| Omnicell, Inc. | 2.22 Billion USD | 94.502% |
| Definitive Healthcare Corp. | 1.82 Billion USD | 93.294% |
| Zhongchao Inc. | 24.41 Million USD | -401.449% |
| Accolade, Inc. | 788.15 Million USD | 84.465% |
| Streamline Health Solutions, Inc. | 41.74 Million USD | -193.333% |
| Ontrak, Inc. | 19.84 Million USD | -516.935% |
| SOPHiA GENETICS SA | 206.15 Million USD | 40.61% |
| R1 RCM Inc. | 4.96 Billion USD | 97.532% |
| Spok Holdings, Inc. | 227.68 Million USD | 46.225% |
| Privia Health Group, Inc. | 999.9 Million USD | 87.755% |
| EUDA Health Holdings Limited | 1.31 Million USD | -9242.713% |
| HeartBeam, Inc. | 17.13 Million USD | -614.71% |
| GeneDx Holdings Corp. | 473.67 Million USD | 74.152% |
| TruBridge, Inc. | 434.42 Million USD | 71.816% |
| Nutex Health, Inc. | 398.24 Million USD | 69.256% |
| Renalytix Plc | 7.97 Million USD | -1435.838% |
| Sharecare, Inc. | 613.63 Million USD | 80.047% |
| Health Catalyst, Inc. | 701.81 Million USD | 82.554% |
| 10x Genomics, Inc. | 965.14 Million USD | 87.314% |
| GoodRx Holdings, Inc. | 1.58 Billion USD | 92.294% |
| SCWorx Corp. | 6.27 Million USD | -1850.188% |
| Schrödinger, Inc. | 802.95 Million USD | 84.752% |
| HealthEquity, Inc. | 3.23 Billion USD | 96.217% |
| HealthStream, Inc. | 499.94 Million USD | 75.51% |
| MSP Recovery, Inc. | 3.15 Billion USD | 96.125% |
| Augmedix, Inc. | 66.71 Million USD | -83.531% |
| BrightSpring Health Services, Inc. Common Stock | 5.79 Billion USD | 97.886% |
| Ontrak, Inc. | 19.84 Million USD | -516.935% |
| SHL Telemedicine Ltd. | 113.04 Million USD | -8.304% |
| CareCloud, Inc. | 79.51 Million USD | -53.982% |
| Premier, Inc. | 3.42 Billion USD | 96.429% |
| Certara, Inc. | 1.56 Billion USD | 92.167% |
| GeneDx Holdings Corp. | 473.67 Million USD | 74.152% |
| OneMedNet Corporation | 463.05 Thousand USD | -26341.021% |
| BrightSpring Health Services, Inc. Tangible Equity Unit | 5.79 Billion USD | 97.886% |
| EUDA Health Holdings Limited | 1.31 Million USD | -9242.713% |
| HeartBeam, Inc. | 17.13 Million USD | -614.71% |
| CareCloud, Inc. | 79.51 Million USD | -53.982% |
| Mangoceuticals, Inc. | 1.05 Million USD | -11551.867% |
| CareMax, Inc. | 623.3 Million USD | 80.357% |
| Healthcare Triangle, Inc. | 10.04 Million USD | -1118.4% |
| Aclarion, Inc. | 2.45 Million USD | -4877.571% |
| OptimizeRx Corporation | 183.37 Million USD | 33.231% |